The 2024 Nobel Prize in Physiology or Medication was awarded Monday to U.S. duo Victor Ambros and Gary Ruvkun for the invention of microRNA — a brand new class of tiny RNA molecules that play an important position in gene regulation.
The 2 scientists have been honored “for his or her discovery of a basic precept governing how gene exercise is regulated,” the Nobel Committee stated in a press release.
The pair’s “groundbreaking discovery revealed a very new precept of gene regulation that turned out to be important for multicellular organisms, together with people,” it stated, including that MicroRNAs “are proving to be basically vital for the way organisms develop and performance.”
Final yr, Katalin Kariko and Drew Weissman received the medication prize for his or her discoveries associated to nucleoside base modifications that enabled the event of mRNA vaccines, which have been crucial within the struggle towards COVID-19.
The drugs prize is awarded for “discoveries which have modified the scientific paradigm and are of nice profit for humankind,” in line with the The Nobel Basis.
The drugs prize shall be adopted by the awards for physics on Tuesday, chemistry on Wednesday and literature on Thursday, whereas the extremely anticipated peace prize will observe on Friday. The prize for financial sciences closes out this yr’s awards on Oct. 14.
